Background
The burden of lower respiratory infection is primarily borne by developing countries. However, the association between particulate matter of different sizes and acute lower respiratory infection (ALRI) outpatient visits in developing countries is less studied.
Methods
We obtained data on ALRI outpatient visits (N = 105,639) from a tertiary hospital in Guangzhou, China between 2013 and 2019. Over-dispersed generalized additive Poisson models were employed to evaluate the excess risk (ER) associated with particulate matter [inhalable particulate matter (PM10), coarse particulate matter (PMc), and fine particulate matter (PM2.5)]. Counterfactual analyses were used to examine the potential percent reduction of ALRI outpatient visits if the levels of air pollution were as low as those recommended by the World Health Organization (WHO).
Results
There were 35,310 pneumonia, 68,218 bronchiolitis, and 2,111 asthma outpatient visits included. Each 10 µg/m3 increase of three-day moving averages of particulate matter was associated with significant ER [95% confidence interval (CI)] of outpatient visits of pneumonia [PM2.5: 3.71% (2.91%, 4.52%); PMc: 9.19% (6.94%, 11.49%); PM10: 4.36% (3.21%, 5.52%)], bronchiolitis [PM2.5: 3.21% (2.49%, 3.93%); PMc: 9.13% (7.09%, 11.21%); PM10: 3.12% (2.10%, 4.15%)], and asthma [PM2.5: 3.45% (1.18%, 5.78%); PMc: 11.69% (4.45%, 19.43%); PM10: 3.33% (0.26%, 6.49%)]. The association between particulate matter and pneumonia outpatient visits was stronger among male patients and in cold seasons. Counterfactual analyses suggested that PM2.5 was associated with the largest potential decline of ALRI outpatient visits [pneumonia: 3.89%, 95% CI: (3.24%, 5.52%); bronchiolitis: 4.35% (3.06%, 4.82%); asthma: 5.98% (1.92%, 10.37%)] if the air pollutants were reduced to the level of the reference guidelines.
Conclusion
Short-term exposure to PM2.5, PMc, and PM10 is associated with significant risk of ALRI outpatient visits, among which PM2.5 is associated with the highest potential decline in outpatient visits if it could be reduced to the WHO recommended level.